Revelation Biosciences, Inc.

REVB • NASDAQ

Revelation Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO James Rolke, with a market cap of $4.3M.

Market Cap$4.3M

Employees9.0

CEOJames Rolke

CountryUnited States of America

Healthcare

Biotechnology

Next EarningsMay 7, 2026 · In 1 weekBefore Market Open · Q1 2026

Income Statement Balance Sheet Cash Flow Business Segments

Financials

View all metrics

Revelation Biosciences, Inc. FAQ

Common questions about Revelation Biosciences, Inc.

Revelation Biosciences, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026 before market open.

Revelation Biosciences, Inc. has approximately 9 employees.

Revelation Biosciences, Inc.

Financials

Revenue

Net Income

Operating Cash Flow

EPS (Diluted)

Revelation Biosciences, Inc. FAQ

When is Revelation Biosciences, Inc.'s next earnings date?

How many employees does Revelation Biosciences, Inc. have?

Cookie Preferences